157 research outputs found
Binary frequency-shift keying (BFSK) transceiver design for galvanic intra-body communications / I.W. Ibrahim … [et al.]
Get PDFThe development of health monitoring technologies has been increasing due to the increasing demand in the healthcare system. In order to continuously monitor critical patient health vital sign such as heart rate and glucose level, communication between the miniature sensor on the human body already successfully deployed using radio frequency (RF) technology, however it's consumed high power. Intra-body communication (IBC) technology is an excellent alternative as it provides flexibility, portability and consumed less power. IBC system used the human body to transfer the transmission data. In this paper, new IBC transceiver based on Binary Frequency Shift Keying (BFSK) was designed. IBC transmitter modulated binary input data to specific frequency before transmitting through the human body. Then IBC receiver demodulated the receiving signal into binary to be processed. The design was implemented using the FPGA board. The galvanic Coupling IBC method was chosen, and the result shows that the receiving data at the receiver is precisely the same as transmitting data
Binary frequency-shift keying (BFSK) transceiver design for Galvanic intra-body communications
No full textThe development of health monitoring technologies has been increasing due to the increasing demand in the healthcare system. In order to continuously monitor critical patient health vital sign such as heart rate and glucose level, communication between the miniature sensor on the human body already successfully deployed using radio frequency (RF) technology, however it\u27s consumed high power. Intra-body communication (IBC) technology is an excellent alternative as it provides flexibility, portability and consumed less power. IBC system used the human body to transfer the transmission data. In this paper, new IBC transceiver based on Binary Frequency Shift Keying (BFSK) was designed. IBC transmitter modulated binary input data to specific frequency before transmitting through the human body. Then IBC receiver demodulated the receiving signal into binary to be processed. The design was implemented using the FPGA board. The galvanic Coupling IBC method was chosen, and the result shows that the receiving data at the receiver is precisely the same as transmitting data
Sulfur capture during fluidized bed combustion of coal: External mass transfer phenomena and the fluid-dynamical behaviour of large particles
No full textApplied Science
Livedo racemosa: A striking dermatological sign for the antiphospholipid syndrome
No full text[No abstract available]Amengual O, 2003, RHEUMATOLOGY, V42, P1029, DOI 10.1093-rheumatology-keg273; Asherson RA, 2006, CLIN EXP RHEUMATOL, V24, pS46; ASHERSON RA, 1989, BRIT J DERMATOL, V120, P215; BAGULEY E, 1988, ANN RHEUM DIS, V47, P702, DOI 10.1136-ard.47.8.702; Cervera R, 2002, ARTHRITIS RHEUM, V46, P1019, DOI 10.1002-art.10187; CHAMPION RH, 1960, P ROY SOC MED, V53, P961; DEVOS J, 1992, DERMATOLOGY, V185, P296; Ehrmann S, 1907, WIEN MED WOCHENSCHR, V57, P777; ENGLERT HJ, 1989, AM J MED, V87, P408; Frances C, 1999, MEDICINE, V78, P209, DOI 10.1097-00005792-199907000-00001; Frances C, 2005, ARTHRITIS RHEUM, V52, P1785, DOI 10.1002-art.21041; Frances C, 2000, J AUTOIMMUN, V15, P139, DOI 10.1006-jaut.2000.0418; Gibbs MB, 2005, J AM ACAD DERMATOL, V52, P1009, DOI 10.1016-j.jaad.2004.11.051; HUGHES GRV, 1984, CLIN EXP DERMATOL, V9, P535, DOI 10.1111-j.1365-2230.1984.tb00856.x; Hughes GRV, 1999, ISRAEL MED ASSOC J, V1, P100; HUGHES GRV, 1983, BRIT MED J, V287, P1088; Hughes GRV, 2003, ANN RHEUM DIS, V62, P1127, DOI 10.1136-ard.2003.006163; KALASHNIKOVA LA, 1990, NEUROLOGY, V40, P464; Karassa FB, 2000, QJM-MON J ASSOC PHYS, V93, P169, DOI 10.1093-qjmed-93.3.169; KESTER S, 1992, ANN EMERG MED, V21, P207, DOI 10.1016-S0196-0644(05)80168-4; Khamashta MA, 2000, J AUTOIMMUN, V15, P249, DOI 10.1006-jaut.2000.0421; Kraemer M, 2005, J NEUROL, V252, P1155, DOI 10.1007-s00415-005-0967-9; LEVINE SR, 1988, NEUROLOGY, V38, P798; Lopez-Pedrera C, 2006, ARTHRITIS RHEUM, V54, P301, DOI 10.1002-art.21549; LUBACH D, 1990, J AM ACAD DERMATOL, V22, P633, DOI 10.1016-0190-9622(90)70087-X; MCHUGH NJ, 1988, ANN RHEUM DIS, V47, P110, DOI 10.1136-ard.47.2.110; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111-j.1538-7836.2006.01753.x; Piette WW, 2000, BRIT J DERMATOL, V142, P1080, DOI 10.1046-j.1365-2133.2000.03590.x; Sangle S, 2005, ANN RHEUM DIS, V64, P147, DOI 10.1136-ard.2004.020743; Sangle SR, 2003, ANN RHEUM DIS, V62, P999, DOI 10.1136-ard.62.10.999; Sangle SR, 2005, RHEUMATOLOGY, V44, P372, DOI 10.1093-rheumatolgy-keh490; Sepp N., 2003, DERMATOLOGY, P1651; SEPP N, 1995, AM J SURG PATHOL, V19, P448, DOI 10.1097-00000478-199504000-00006; SHEALY CN, 1970, J AMER MED ASSOC, V212, P1522; SNEDDON IB, 1965, BRIT J DERMATOL, V77, P180, DOI 10.1111-j.1365-2133.1965.tb14628.x; Tietjen GE, 2002, HEADACHE, V42, P352, DOI 10.1046-j.1526-4610.2002.02106.x; Toubi E, 2005, CLIN EXP RHEUMATOL, V23, P499; WEINSTEIN C, 1987, ARCH DERMATOL, V123, P596, DOI 10.1001-archderm.123.5.596; WEST SG, 1995, AM J MED, V99, P153, DOI 10.1016-S0002-9343(99)80135-1; Wohlrab J, 2001, BRIT J DERMATOL, V145, P285, DOI 10.1046-j.1365-2133.2001.04348.x; ZELGER B, 1993, ARCH DERMATOL, V129, P437, DOI 10.1001-archderm.129.4.437; ZELGER B, 1992, HUM PATHOL, V23, P668, DOI 10.1016-0046-8177(92)90323-U40292
Livedo racemosa: A striking dermatological sign for the antiphospholipid syndrome
No full text[No abstract available]Amengual O, 2003, RHEUMATOLOGY, V42, P1029, DOI 10.1093-rheumatology-keg273; Asherson RA, 2006, CLIN EXP RHEUMATOL, V24, pS46; ASHERSON RA, 1989, BRIT J DERMATOL, V120, P215; BAGULEY E, 1988, ANN RHEUM DIS, V47, P702, DOI 10.1136-ard.47.8.702; Cervera R, 2002, ARTHRITIS RHEUM, V46, P1019, DOI 10.1002-art.10187; CHAMPION RH, 1960, P ROY SOC MED, V53, P961; DEVOS J, 1992, DERMATOLOGY, V185, P296; Ehrmann S, 1907, WIEN MED WOCHENSCHR, V57, P777; ENGLERT HJ, 1989, AM J MED, V87, P408; Frances C, 1999, MEDICINE, V78, P209, DOI 10.1097-00005792-199907000-00001; Frances C, 2005, ARTHRITIS RHEUM, V52, P1785, DOI 10.1002-art.21041; Frances C, 2000, J AUTOIMMUN, V15, P139, DOI 10.1006-jaut.2000.0418; Gibbs MB, 2005, J AM ACAD DERMATOL, V52, P1009, DOI 10.1016-j.jaad.2004.11.051; HUGHES GRV, 1984, CLIN EXP DERMATOL, V9, P535, DOI 10.1111-j.1365-2230.1984.tb00856.x; Hughes GRV, 1999, ISRAEL MED ASSOC J, V1, P100; HUGHES GRV, 1983, BRIT MED J, V287, P1088; Hughes GRV, 2003, ANN RHEUM DIS, V62, P1127, DOI 10.1136-ard.2003.006163; KALASHNIKOVA LA, 1990, NEUROLOGY, V40, P464; Karassa FB, 2000, QJM-MON J ASSOC PHYS, V93, P169, DOI 10.1093-qjmed-93.3.169; KESTER S, 1992, ANN EMERG MED, V21, P207, DOI 10.1016-S0196-0644(05)80168-4; Khamashta MA, 2000, J AUTOIMMUN, V15, P249, DOI 10.1006-jaut.2000.0421; Kraemer M, 2005, J NEUROL, V252, P1155, DOI 10.1007-s00415-005-0967-9; LEVINE SR, 1988, NEUROLOGY, V38, P798; Lopez-Pedrera C, 2006, ARTHRITIS RHEUM, V54, P301, DOI 10.1002-art.21549; LUBACH D, 1990, J AM ACAD DERMATOL, V22, P633, DOI 10.1016-0190-9622(90)70087-X; MCHUGH NJ, 1988, ANN RHEUM DIS, V47, P110, DOI 10.1136-ard.47.2.110; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111-j.1538-7836.2006.01753.x; Piette WW, 2000, BRIT J DERMATOL, V142, P1080, DOI 10.1046-j.1365-2133.2000.03590.x; Sangle S, 2005, ANN RHEUM DIS, V64, P147, DOI 10.1136-ard.2004.020743; Sangle SR, 2003, ANN RHEUM DIS, V62, P999, DOI 10.1136-ard.62.10.999; Sangle SR, 2005, RHEUMATOLOGY, V44, P372, DOI 10.1093-rheumatolgy-keh490; Sepp N., 2003, DERMATOLOGY, P1651; SEPP N, 1995, AM J SURG PATHOL, V19, P448, DOI 10.1097-00000478-199504000-00006; SHEALY CN, 1970, J AMER MED ASSOC, V212, P1522; SNEDDON IB, 1965, BRIT J DERMATOL, V77, P180, DOI 10.1111-j.1365-2133.1965.tb14628.x; Tietjen GE, 2002, HEADACHE, V42, P352, DOI 10.1046-j.1526-4610.2002.02106.x; Toubi E, 2005, CLIN EXP RHEUMATOL, V23, P499; WEINSTEIN C, 1987, ARCH DERMATOL, V123, P596, DOI 10.1001-archderm.123.5.596; WEST SG, 1995, AM J MED, V99, P153, DOI 10.1016-S0002-9343(99)80135-1; Wohlrab J, 2001, BRIT J DERMATOL, V145, P285, DOI 10.1046-j.1365-2133.2001.04348.x; ZELGER B, 1993, ARCH DERMATOL, V129, P437, DOI 10.1001-archderm.129.4.437; ZELGER B, 1992, HUM PATHOL, V23, P668, DOI 10.1016-0046-8177(92)90323-U40292
The use of sildenafil in pediatric Takayasu arteritis
No full text[No abstract available]Kumana CR, 2004, ANN RHEUM DIS, V63, P1522, DOI 10.1136-ard.2003.015677; Lichtenstein JR, 2003, ARTHRITIS RHEUM, V48, P282, DOI 10.1002-art.1062833
Livedo racemosa: A striking dermatological sign for the antiphospholipid syndrome
No full text[No abstract available]Amengual O, 2003, RHEUMATOLOGY, V42, P1029, DOI 10.1093-rheumatology-keg273; Asherson RA, 2006, CLIN EXP RHEUMATOL, V24, pS46; ASHERSON RA, 1989, BRIT J DERMATOL, V120, P215; BAGULEY E, 1988, ANN RHEUM DIS, V47, P702, DOI 10.1136-ard.47.8.702; Cervera R, 2002, ARTHRITIS RHEUM, V46, P1019, DOI 10.1002-art.10187; CHAMPION RH, 1960, P ROY SOC MED, V53, P961; DEVOS J, 1992, DERMATOLOGY, V185, P296; Ehrmann S, 1907, WIEN MED WOCHENSCHR, V57, P777; ENGLERT HJ, 1989, AM J MED, V87, P408; Frances C, 1999, MEDICINE, V78, P209, DOI 10.1097-00005792-199907000-00001; Frances C, 2005, ARTHRITIS RHEUM, V52, P1785, DOI 10.1002-art.21041; Frances C, 2000, J AUTOIMMUN, V15, P139, DOI 10.1006-jaut.2000.0418; Gibbs MB, 2005, J AM ACAD DERMATOL, V52, P1009, DOI 10.1016-j.jaad.2004.11.051; HUGHES GRV, 1984, CLIN EXP DERMATOL, V9, P535, DOI 10.1111-j.1365-2230.1984.tb00856.x; Hughes GRV, 1999, ISRAEL MED ASSOC J, V1, P100; HUGHES GRV, 1983, BRIT MED J, V287, P1088; Hughes GRV, 2003, ANN RHEUM DIS, V62, P1127, DOI 10.1136-ard.2003.006163; KALASHNIKOVA LA, 1990, NEUROLOGY, V40, P464; Karassa FB, 2000, QJM-MON J ASSOC PHYS, V93, P169, DOI 10.1093-qjmed-93.3.169; KESTER S, 1992, ANN EMERG MED, V21, P207, DOI 10.1016-S0196-0644(05)80168-4; Khamashta MA, 2000, J AUTOIMMUN, V15, P249, DOI 10.1006-jaut.2000.0421; Kraemer M, 2005, J NEUROL, V252, P1155, DOI 10.1007-s00415-005-0967-9; LEVINE SR, 1988, NEUROLOGY, V38, P798; Lopez-Pedrera C, 2006, ARTHRITIS RHEUM, V54, P301, DOI 10.1002-art.21549; LUBACH D, 1990, J AM ACAD DERMATOL, V22, P633, DOI 10.1016-0190-9622(90)70087-X; MCHUGH NJ, 1988, ANN RHEUM DIS, V47, P110, DOI 10.1136-ard.47.2.110; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111-j.1538-7836.2006.01753.x; Piette WW, 2000, BRIT J DERMATOL, V142, P1080, DOI 10.1046-j.1365-2133.2000.03590.x; Sangle S, 2005, ANN RHEUM DIS, V64, P147, DOI 10.1136-ard.2004.020743; Sangle SR, 2003, ANN RHEUM DIS, V62, P999, DOI 10.1136-ard.62.10.999; Sangle SR, 2005, RHEUMATOLOGY, V44, P372, DOI 10.1093-rheumatolgy-keh490; Sepp N., 2003, DERMATOLOGY, P1651; SEPP N, 1995, AM J SURG PATHOL, V19, P448, DOI 10.1097-00000478-199504000-00006; SHEALY CN, 1970, J AMER MED ASSOC, V212, P1522; SNEDDON IB, 1965, BRIT J DERMATOL, V77, P180, DOI 10.1111-j.1365-2133.1965.tb14628.x; Tietjen GE, 2002, HEADACHE, V42, P352, DOI 10.1046-j.1526-4610.2002.02106.x; Toubi E, 2005, CLIN EXP RHEUMATOL, V23, P499; WEINSTEIN C, 1987, ARCH DERMATOL, V123, P596, DOI 10.1001-archderm.123.5.596; WEST SG, 1995, AM J MED, V99, P153, DOI 10.1016-S0002-9343(99)80135-1; Wohlrab J, 2001, BRIT J DERMATOL, V145, P285, DOI 10.1046-j.1365-2133.2001.04348.x; ZELGER B, 1993, ARCH DERMATOL, V129, P437, DOI 10.1001-archderm.129.4.437; ZELGER B, 1992, HUM PATHOL, V23, P668, DOI 10.1016-0046-8177(92)90323-U40292
- …
